Sequence analysis of the BSP products (on average 7–9 independent clones for each carcinoma) of these 10 carcinomas revealed that in 6 carcinomas the promoter is hypermethylated in good agreement with the COBRA results (Figure 3C). This evidence concerns the gene IBSP and carcinoma.